Connection

Galia Rahav to Secondary Prevention

This is a "connection" page, showing publications Galia Rahav has written about Secondary Prevention.
Connection Strength

0.154
  1. Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence. Clin Infect Dis. 2018 08 16; 67(5):649-656.
    View in: PubMed
    Score: 0.126
  2. Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. N Engl J Med. 2017 01 26; 376(4):305-317.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.